EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy

Shaomin Shi iD, Xinghua Chen, Wen Yu, Xiaolan Ke, Tean Ma iD

Endocrine Connections · 31.07.2023 · 12 (10)

DOI: 10.1530/ec-23-0284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Connections, erschienen am 31.07.2023. Verfasst von Shaomin Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protection of podocytes is one of the important means to delay the progression of diabetic nephropathy (DN), and glucagon-like peptide-1 (GLP-1) has been shown to have a protective effect on the kidney in DN models, but whether it has a protective effect on podocytes and the potential mechanisms of action remain largely unknown. In the present study, we established a type 2 diabetes mellitus (T2DM) mouse model by high-fat diet feeding combined with streptozotocin (STZ) induction and administered the intervention for 14 weeks. We found that liraglutide significantly ameliorated podocyte injury in DN mice. Mechanistically, we detected glucagon-like peptide-1 receptor (GLP-1R) protein expression levels in kidney tissues by immunohistochemical staining, immunofluorescence staining, and western blotting and found that podocytes could express GLP-1R and liraglutide treatment could restore GLP-1R expression in the kidney tissues of DN mice. Furthermore, we found that NLRP3-induced inflammation and pyroptosis were positively correlated with podocyte injury in DN mice, and liraglutide inhibited the expression of NLRP3-induced inflammation and pyroptosis-related proteins. Our results suggest that liraglutide protects DN mouse podocytes by regulating GLP-1R in renal tissues and by regulating NLRP3-induced inflammation and pyroptosis.

Schlagwörter

Stichwörter der Autor:innen

diabetic nephropathyglucagon-like peptide-1 receptorliraglutidepodocytespyroptosis

Autor:innen und Institutionen

  • Division of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
  • Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Immunology, School of Medicine, Yangtze University, Jingzhou, China.

ORCID-Profile: Shaomin Shi, Tean Ma

Zitieren

APA

Shi, S., Chen, X., Yu, W., Ke, X., & Ma, T. (2023). Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy. Endocrine Connections, 12(10). https://doi.org/10.1530/ec-23-0284

Vancouver

Shi S, Chen X, Yu W, Ke X, Ma T. Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy. Endocrine Connections. 2023;12(10). doi:10.1530/ec-23-0284

BibTeX
@article{Shi2023,
  author = {Shi, Shaomin and Chen, Xinghua and Yu, Wen and Ke, Xiaolan and Ma, Tean},
  title = {Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy},
  journal = {Endocrine Connections},
  year = {2023},
  volume = {12},
  number = {10},
  doi = {10.1530/ec-23-0284}
}
Kostenlos starten →